Royal Bank of Canada grew its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 24.0% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,339,913 shares of the real estate investment trust's stock after purchasing an additional 258,914 shares during the quarter. Royal Bank of Canada owned approximately 0.19% of Healthpeak Properties worth $27,093,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds also recently made changes to their positions in DOC. Invesco Ltd. increased its holdings in Healthpeak Properties by 20.7% in the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock worth $467,311,000 after acquiring an additional 3,967,830 shares in the last quarter. Fuller & Thaler Asset Management Inc. boosted its holdings in Healthpeak Properties by 6.5% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 18,397,841 shares of the real estate investment trust's stock worth $372,004,000 after buying an additional 1,129,924 shares during the period. Centersquare Investment Management LLC boosted its holdings in Healthpeak Properties by 18.5% in the 1st quarter. Centersquare Investment Management LLC now owns 13,285,932 shares of the real estate investment trust's stock worth $268,642,000 after buying an additional 2,070,416 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Healthpeak Properties by 0.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 10,392,052 shares of the real estate investment trust's stock worth $210,126,000 after buying an additional 76,978 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Healthpeak Properties by 0.8% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 10,238,001 shares of the real estate investment trust's stock worth $207,012,000 after buying an additional 84,551 shares during the period. 93.57% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In related news, CEO Scott M. Brinker purchased 1,490 shares of the firm's stock in a transaction that occurred on Monday, August 4th. The shares were bought at an average price of $16.83 per share, for a total transaction of $25,076.70. Following the acquisition, the chief executive officer owned 211,906 shares of the company's stock, valued at approximately $3,566,377.98. This represents a 0.71% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In the last 90 days, insiders acquired 8,783 shares of company stock worth $150,129. Corporate insiders own 0.23% of the company's stock.
Analysts Set New Price Targets
Several research analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a $18.00 target price (down previously from $28.00) on shares of Healthpeak Properties in a report on Wednesday, August 20th. Morgan Stanley dropped their price target on Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating for the company in a research note on Friday, August 22nd. Wall Street Zen downgraded Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Robert W. Baird set a $21.00 price target on Healthpeak Properties and gave the stock an "outperform" rating in a research note on Wednesday, July 30th. Finally, Scotiabank downgraded Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and dropped their price target for the stock from $21.00 to $19.00 in a research note on Tuesday, July 29th. Seven investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $21.50.
Get Our Latest Research Report on DOC
Healthpeak Properties Price Performance
Shares of NYSE DOC traded down $0.02 during midday trading on Friday, reaching $18.13. 556,236 shares of the stock traded hands, compared to its average volume of 6,062,861. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28. The stock has a market capitalization of $12.60 billion, a PE ratio of 75.65, a P/E/G ratio of 2.31 and a beta of 1.07. Healthpeak Properties, Inc. has a one year low of $16.63 and a one year high of $23.26. The company's 50 day moving average is $17.76 and its 200 day moving average is $18.21.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The company had revenue of $694.35 million for the quarter, compared to analyst estimates of $697.14 million. During the same quarter in the prior year, the firm posted $0.45 EPS. Healthpeak Properties's quarterly revenue was down .2% compared to the same quarter last year. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.
Healthpeak Properties Announces Dividend
The business also recently declared a monthly dividend, which was paid on Friday, August 29th. Investors of record on Monday, August 18th were issued a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 6.7%. The ex-dividend date was Monday, August 18th. Healthpeak Properties's dividend payout ratio is presently 508.33%.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
